Diabetes, Obesity and Metabolism logo Wiley-Blackwell logo

Publisher: Wiley-Blackwell

Related content
Volume 4, Number 3, May 2002

< previous issue | all issues | next issue >

Role of leptin in glucose metabolism in type 2 diabetes
pp. 147-155(9)
Authors: Al-Daghri, N.; Bartlett, W. A.; Jones, A. F.; Kumar, S.

Hormonal influences on lipoprotein(a) metabolism
pp. 156-165(10)
Authors: Pang, R. W. C.; Lam, K. S. L.

Nateglinide improves glycaemic control when added to metformin monotherapy: results of a randomized trial with type 2 diabetes patients
pp. 177-186(10)
Authors: Marre, M.; Van Gaal, L.; Usadel, K-H.; Ball, M.; Whatmough, I.; Guitard, C.

Effect of misoprostol (PGE1) on glucose metabolism in type-2-diabetic and control subjects
pp. 195-200(6)
Authors: Lee, N. A.; Matsuda, M.; Bressler, P.; Pratipanawatr, T.; Glass, L.; Mandarino, L. J.; DeFronzo, R. A.

Simultaneous glyburide/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetes
pp. 201-208(8)
Authors: Garber, A. J.; Larsen, J.; Schneider, S. H.; Piper, B. A.; Henry, D.

The regulation of HSL and LPL expression by DHT and flutamide in human subcutaneous adipose tissue
pp. 209-213(5)
Authors: Anderson, L. A.; McTernan, P. G.; Harte, A. L; Barnett, A. H.; Kumar, S.

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page